Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study - Egyptian Knowledge Bank - troweb

387697

Efficacy and safety of transfusing plasma from COVID-19 survivors to COVID-19 victims with severe illness. A double-blinded controlled preliminary study

Article

Last updated: 31 Dec 2024

Overview Similar Items

Article

Efficacy and Safety of Tocilizumab in COVID-19 Patients: Retrospective Study

Article

Study of the relation between Plasma Transfusion and Clinical Outcome in Critically Ill Children at Pediatric Intensive Care Unit

Article

Study of Plasminogen activator inhibitor-1 (PAI-1) in hospitalized COVID-19 patients

Article

Serum Plasmin(ogen) Level as a Predictor for COVID-19 Severity: A Pilot Study from Egypt

Article

Comparative study between the therapeutic effect of Remdesivir versus Hydroxychloroquine in Covid-19 hospitalized patients.

Article

Effect of Colchicine in Treating Severe COVID-19 Patients on Hospital Discharge: Retrospective Cohort Study

Article

A multicentric study to correlate severity of disease and vaccine in COVID-19 pandemic

Article

Efficacy of Hematological Biomarkers as Prognostic Factors for the Severity and Mortality of COVID-19 Patients at Suez Canal University Hospital

Article

Clinical Outcomes of Implementing Two Management Protocols for Acute Respiratory Distress Patients with COVID-19: A Randomized Controlled Trial

Article

Effect of Aspirin Use on clinical Outcome among Critically Ill Patients with COVID- 19